[1]Cambronero F,Vilchez JA,Garcia-Honrubia A,et al.Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy[J].Thromb Res,2010,126:e46-50. [2]Luo GP,Ni B,Yang X,et al.von Willebrand factor: more than a regulator of hemostasis and thrombosis[J].Acta Heamatol,2012,128:158-169. [3]Mojiri A,Stoletov K,Carrillo MA,et al.Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin[J].Oncotarget,2017,8:13015-13029. [4]张立,李能莲,舍雅莉,等.血管性血友病因子与不同转移潜能人肺癌细胞转移的相关性研究[J].甘肃中医学院学报,2013,30:6-8. [5]Chambers AF,Groom AC,MacDonaid IC.Dissemination and growth of cancer cells in metastatic sites[J].Nat Rev Cancer,2002,2:586-572. [6]Gay LJ,Felding-Habermann B.Contribution of platelets to tumour metastasis[J].Nat Rev Cancer,2011,11:123-134. [7]吴子晏,杨述华.vWF在骨肉瘤中的表达及与肺转移的关系[J].中国骨肿瘤骨病,2007,6:216-219. [8]Yang X,Sun HJ,Li ZR.et al.Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascularendothelial growth factor and related to disease severity[J].BMC Cancer,2015,15:80. [9]Liu Y,Wang X,Li S,et al.The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma:a quantitative proteomic based study[J].J Proteomics,2014,106:99-112. [10]Eppert K,Wunder JS,Aneliunas V,et al.Von willebrand factor expression inosteosarco metastasis[J].Mod Pathol,2005,18:388-397. [11]蔡玮,郭应芳,王玲,等.甲状腺未分化癌组织vWF表达与血管生成拟态相关性研究[J].中华肿瘤防治杂志,2017,24:684-688. [12]Yang AJ,Wang M,Wang Y,et al.Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma[J].Oncogenesis,2018,7:12. [13]梁汉霖,彭杰文,张俊凯,等.miR-10b通过调节vWF抑制肺癌细胞侵袭和迁移[J].浙江中医杂志, 2009, 44:313-315. |